Afsaneh Abdolzade-Bavil

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 3

Top Topics

Recombinant Human

Clinical Evaluation

Induced Pluripotent Stem Cells

Top Venues

Clinical pharmacology and therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Sara Belli, Maria Amann, Lucy Hutchinson, Laurène Pousse, Afsaneh Abdolzade-Bavil, Nicole Justies, Bjoern Jacobsen, Corinne Ploix, Eleni Tselempi, Vinko Tosevski, Hans Koll, Gabriel Schnetzler, Christophe Boetsch, Estelle Marrer-Berger
Optimizing Early Clinical Investigations in Cancer Immunotherapy: The Translational Journey of RG6292, a Novel, Selective Treg-Depleting Antibody. Clinical pharmacology and therapeutics 116 (3) (2024)
Sara Belli, Maria Amann, Lucy Hutchinson, Laurène Pousse, Afsaneh Abdolzade-Bavil, Nicole Justies, Bjoern Jacobsen, Corinne Ploix, Eleni Tselempi, Vinko Tosevski, Hans Koll, Gabriel Schnetzler, Christophe Boetsch, Estelle Marrer-Berger
Optimizing Early Clinical Investigations in Cancer Immunotherapy: The Translational Journey of RG6292, a Novel, Selective Treg-Depleting Antibody. Clinical pharmacology and therapeutics (2024)
Christian Künzel, Afsaneh Abdolzade-Bavil, Alfred M Engel, Mirko Pleitner, Eginhard Schick, Kay Stubenrauch
Assay concept for detecting anti-drug IgM in human serum samples by using a novel recombinant human IgM positive control. Bioanalysis 13 (4) (2021)